See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: April 19, 2005

Healthy Children Studies Fredrickson Type III Hyperlipoproteinemia Borderline Personality Disorders

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Healthy Children Studies

Healthy male and female volunteers ages 18-35 are needed to participate in this study of an investigational flu vaccine. Research site located in Charlottesville, Va.

More Information

Please see http://www.centerwatch.com/patient/studies/cat576.html.

-----

Fredrickson Type III Hyperlipoproteinemia

This study will evaluate the safety and efficacy of an investigational medication in people with Fredrickson Type III Hyperlipoproteinemia. Eligible men and women must be 18 or older. Research site located in Portage, Mich.

More Information

Please see http://www.centerwatch.com/patient/studies/cat659.html.

-----

Borderline Personality Disorders

The study is being sponsored by the pharmaceutical company GlaxoSmithKline. Its purpose is to evaluate the effectiveness of the medication Lamotrigine in the treatment of emotional instability in borderline personality disorder among women between ages 18 and 64. Research site located in Belmont, Mass.

More Information

Please see http://www.centerwatch.com/patient/studies/cat21.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.